Profiles of Basal and stimulated receptor signaling networks predict drug response in breast cancer lines.
Ontology highlight
ABSTRACT: Identifying factors responsible for variation in drug response is essential for the effective use of targeted therapeutics. We profiled signaling pathway activity in a collection of breast cancer cell lines before and after stimulation with physiologically relevant ligands, which revealed the variability in network activity among cells of known genotype and molecular subtype. Despite the receptor-based classification of breast cancer subtypes, we found that the abundance and activity of signaling proteins in unstimulated cells (basal profile), as well as the activity of proteins in stimulated cells (signaling profile), varied within each subtype. Using a partial least-squares regression approach, we constructed models that significantly predicted sensitivity to 23 targeted therapeutics. Fo
SUBMITTER: Niepel M
PROVIDER: S-EPMC3845839 | biostudies-literature | 2013 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA